ASAP Blog

Posted By Michael Burke, Monday, March 1, 2021 ASAP audiences have learned a lot from Jay McBain, principal analyst for channel partnerships and alliances at Forrester Research. His writings, past addresses to the ASAP Global Alliance Summit, and other appearances in print and in person have... Continue Reading

Posted By Jon Lavietes, Thursday, February 18, 2021 Yes, 2020 was a rough year for most, but if there was any consolation for alliance managers it’s that the value of partnerships has never been clearer than in these pandemic circumstances. Of course, with increased scrutiny comes more... Continue Reading

Posted By Jon Lavietes, Friday, February 12, 2021 You can’t excel at any craft if you don’t fine-tune your tools and techniques. The 2021 ASAP Global Alliance Summit, the alliance professional’s best annual forum for learning new tricks of the trade, is a little over a month... Continue Reading

Posted By Jon Lavietes, Thursday, January 28, 2021 Ben Gomes-Casseres, CSAP, an author, ASAP thought leader, and professor at Brandeis University who has studied alliance strategy for more than three decades and still teaches a class on alliance management, kicked off this year’s ASAP... Continue Reading

Posted By Jon Lavietes, Friday, January 8, 2021 The IT and biopharma industries make up a good portion of the strategic alliance and ASAP communities’ foundation. For many years, these two verticals worked largely in separate spheres where they approached alliances in different ways that... Continue Reading

Posted By Jon Lavietes, Wednesday, November 25, 2020 Biopharma alliances have been steadily growing in number and complexity. In the early drug development phases, companies are shifting R&D responsibilities to an increasingly diverse array of CROs, academic institutions, startups,... Continue Reading

Posted By Jon Lavietes, Friday, November 20, 2020 Groundbreaking medical treatments come in many forms. The average person is likely to associate the pharmaceutical industry’s role in healing with prescription and over-the-counter drugs. While the pills, capsules, tablets, and liquids they... Continue Reading

Posted By Jon Lavietes, Friday, November 13, 2020 Mergers, acquisitions, and divestments is a different world from alliance management, yet these disciplines end up overlapping from time to time, so some alliance managers have gotten a taste of it in small doses. Should alliance managers dip their... Continue Reading

Posted By Jon Lavietes, Monday, October 19, 2020 Clinical trials have undergone a bit of a transformation in recent years. Much like what has happened with pharmaceutical manufacturing operations over the last decade and more, clinical trial site management is becoming less transactional and more... Continue Reading

Posted By Contributed by: Wissam “Will” Yafi, Founder & CEO – TIDWIT , Wednesday, October 7, 2020Updated: Tuesday, October 6, 2020 Last year I had a memorable lunch conversation with an alliance vice president of a very large tech GSI. “We have had an alliance... Continue Reading

Posted By Jon Lavietes, Monday, October 5, 2020 The ASAP biopharma community is no stranger to big pharma–biotech alliances and David-Goliath partnerships. In general, the story usually centers around an entity with an intriguing molecule accompanied by promising science looking for a... Continue Reading

Posted By Michael J. Burke, Monday, October 5, 2020 The road to digital health has been paved with good intentions: it’s about helping people take charge of their own health and wellness, after all. But it’s been a rocky road as well, and for pharma and tech companies taking the trip... Continue Reading